A Randomised, Double Blind, Placebo-controlled Study to Determine the Efficacy of Immune Modulation Therapy in the Treatment of Patients Suffering from Peripheral Arterial Occlusive Disease with Intermittent Claudication-Reference-Cited by-同舟云学术

A Randomised, Double Blind, Placebo-controlled Study to Determine the Efficacy of Immune Modulation Therapy in the Treatment of Patients Suffering from Peripheral Arterial Occlusive Disease with Intermittent Claudication

Published:2002-05 Issue:5 Volume:23 Page:381-387
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

McGrath C.,Robb R.,Lucas A.J.,Stewart A.H.R.,Underwood C.L.,Horridge J.K.,Lamont P.M.,Smith F.C.T.,Baird R.N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference34 articles.

1. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurement in a population study of 60 year old men and women;Schroll;J Chron Dis,1981

2. Peripheral arterial disease in the elderly: The Rotterdam Study;Meijer;Arterioscler Thromb Vasc Biol,1997

3. Exercise training improves functional status in patients with peripheral arterial disease;Regensteiner;J Vasc Surg,1996

4. Benefit of exercise conditioning for patients with peripheral arterial disease;Hiatt;Circulation,1990

5. Treating claudication in five words;Housley;Br Med J (Clin Res Ed),1988

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial;Complementary Therapies in Medicine;2009-10

2. Effects of therapy using the Celacade system on structural and functional cardiac remodelling in rats following myocardial infarction;Canadian Journal of Cardiology;2009-07

3. Natural History and Medical Management of Chronic Lower Extremity Ischemia;Comprehensive Vascular and Endovascular Surgery;2009

4. Device-Based Nonspecific Immunomodulation Therapy (Celacade), and Its Potential Role in the Treatment of Chronic Heart Failure;Cardiology in Review;2008-11

5. Optimal risk factor modification and medical management of the patient with peripheral arterial disease;Catheterization and Cardiovascular Interventions;2008